313 related articles for article (PubMed ID: 23280874)
41. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli.
Zeng W; Azzopardi K; Hocking D; Wong CY; Robevska G; Tauschek M; Robins-Browne RM; Jackson DC
Vaccine; 2012 Jul; 30(32):4800-6. PubMed ID: 22634295
[TBL] [Abstract][Full Text] [Related]
42. Synthetic MUC1 Antitumor Vaccine Candidates with Varied Glycosylation Pattern Bearing R/S-configured Pam3 CysSerLys4.
Shi L; Cai H; Huang ZH; Sun ZY; Chen YX; Zhao YF; Kunz H; Li YM
Chembiochem; 2016 Aug; 17(15):1412-5. PubMed ID: 27188544
[TBL] [Abstract][Full Text] [Related]
43. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.
Azmi F; Ahmad Fuaad AA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Bioorg Med Chem; 2014 Nov; 22(22):6401-8. PubMed ID: 25438764
[TBL] [Abstract][Full Text] [Related]
44. A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy.
Huang ZH; Shi L; Ma JW; Sun ZY; Cai H; Chen YX; Zhao YF; Li YM
J Am Chem Soc; 2012 May; 134(21):8730-3. PubMed ID: 22587010
[TBL] [Abstract][Full Text] [Related]
45. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
[TBL] [Abstract][Full Text] [Related]
46. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.
Lakshminarayanan V; Thompson P; Wolfert MA; Buskas T; Bradley JM; Pathangey LB; Madsen CS; Cohen PA; Gendler SJ; Boons GJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):261-6. PubMed ID: 22171012
[TBL] [Abstract][Full Text] [Related]
47. Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases.
Niederhafner P; Reinis M; Sebestík J; Jezek J
J Pept Sci; 2008 May; 14(5):556-87. PubMed ID: 18275089
[TBL] [Abstract][Full Text] [Related]
48. Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin.
Wittrock S; Becker T; Kunz H
Angew Chem Int Ed Engl; 2007; 46(27):5226-30. PubMed ID: 17546719
[No Abstract] [Full Text] [Related]
49. First self-adjuvant multicomponent potential vaccine candidates by tethering of four or eight MUC1 antigenic immunodominant PDTRP units on a calixarene platform: synthesis and biological evaluation.
Geraci C; Consoli GM; Granata G; Galante E; Palmigiano A; Pappalardo M; Di Puma SD; Spadaro A
Bioconjug Chem; 2013 Oct; 24(10):1710-20. PubMed ID: 24041198
[TBL] [Abstract][Full Text] [Related]
50. Peptide vaccines and peptide libraries.
Wiesmüller KH; Fleckenstein B; Jung G
Biol Chem; 2001 Apr; 382(4):571-9. PubMed ID: 11405221
[TBL] [Abstract][Full Text] [Related]
51. Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.
Ryan SO; Turner MS; Gariépy J; Finn OJ
Cancer Res; 2010 Jul; 70(14):5788-96. PubMed ID: 20587526
[TBL] [Abstract][Full Text] [Related]
52. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
53. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.
Chuang HY; Ren CT; Chao CA; Wu CY; Shivatare SS; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2013 Jul; 135(30):11140-50. PubMed ID: 23819648
[TBL] [Abstract][Full Text] [Related]
55. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
56. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.
Thompson P; Lakshminarayanan V; Supekar NT; Bradley JM; Cohen PA; Wolfert MA; Gendler SJ; Boons GJ
Chem Commun (Camb); 2015 Jun; 51(50):10214-7. PubMed ID: 26022217
[TBL] [Abstract][Full Text] [Related]
57. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
Davila E; Kennedy R; Celis E
Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
[TBL] [Abstract][Full Text] [Related]
58. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
Lo-Man R; Vichier-Guerre S; Bay S; Dériaud E; Cantacuzène D; Leclerc C
J Immunol; 2001 Feb; 166(4):2849-54. PubMed ID: 11160353
[TBL] [Abstract][Full Text] [Related]
59. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
[TBL] [Abstract][Full Text] [Related]
60. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S
J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
